Clinical Trial Update: 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration [Phase 3]

View source ↗

Summary

Phase 3 trial update for 4D-150 in patients with macular neovascularization due to age-related macular degeneration, currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• 4D-150

Snippet

Sponsor: 4D Molecular Therapeutics | Conditions: Macular Neovascularization Secondary to Age-Related Macular Degeneration | Phase 3 | Status: ACTIVE_NOT_RECRUITING